Compare NRC & MCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NRC | MCI |
|---|---|---|
| Founded | 1981 | 1971 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 428.2M | 410.7M |
| IPO Year | 1997 | N/A |
| Metric | NRC | MCI |
|---|---|---|
| Price | $16.06 | $20.18 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 111.6K | 18.5K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | 3.93% | ★ 8.46% |
| EPS Growth | ★ 4707.69 | N/A |
| EPS | ★ 50.00 | 1.82 |
| Revenue | ★ $119,686,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ $0.33 | $11.02 |
| Revenue Growth | ★ 1.81 | N/A |
| 52 Week Low | $9.76 | $18.00 |
| 52 Week High | $22.79 | $23.79 |
| Indicator | NRC | MCI |
|---|---|---|
| Relative Strength Index (RSI) | 56.78 | 43.95 |
| Support Level | $14.78 | $19.31 |
| Resistance Level | $16.63 | $21.19 |
| Average True Range (ATR) | 0.94 | 0.34 |
| MACD | 0.58 | -0.08 |
| Stochastic Oscillator | 80.21 | 24.21 |
National Research Corp is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers, and other healthcare organizations. Its portfolio of solutions represents a set of capabilities that individually and collectively provide value to clients. It operates in the United States and Canada, of which key revenue is derived from the United States.
Barings Corporate Investors is a closed-end management investment company. Its investment objective is to maintain a portfolio of securities providing a current yield and an opportunity for capital gains. The Trust's principal investments are privately placed, below-investment grade, long-term debt obligations, including bank loans and mezzanine debt instruments. The Trust typically purchases these investments, which are not publicly tradable, directly from their issuers in private placement transactions, and the investments are typically made to small or middle market companies.